drug
ZIPRASIDONE MESYLATE
Marketedupdated 3mo agoby MSN Laboratories Pvt Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1indications
investigational
Schizophrenia
all catalysts(5)
approval · 5
Dec 26, 2019
approval
ZIPRASIDONE MESYLATE — FDA approval
ZIPRASIDONE MESYLATE
→
Feb 2, 2021
approval
ZIPRASIDONE MESYLATE — FDA approval
ZIPRASIDONE MESYLATE
→
Feb 2, 2021
approval
ZIPRASIDONE MESYLATE — FDA approval
ZIPRASIDONE MESYLATE
→
Aug 8, 2023
approval
ZIPRASIDONE MESYLATE — FDA approval
ZIPRASIDONE MESYLATE
→
Oct 9, 2025
approval
ZIPRASIDONE MESYLATE — FDA approval
ZIPRASIDONE MESYLATE
→
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that